Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lifestyle changes may boost gut health in melanoma fight

NCT ID NCT04866810

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 41 times

Summary

This study looks at whether a high-fiber, plant-based diet and regular exercise can change the gut microbiome in people with melanoma who are receiving immunotherapy. Researchers want to see if these lifestyle changes are feasible and if they might affect how well the treatment works. The study involves 24 adults and is conducted remotely via phone or video calls.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Loma Linda University

    Loma Linda, California, 92350, United States

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

High-fiber, plant-based diet and exercise prescription

What this could lead to

If successful, this could show that lifestyle changes can influence the gut microbiome and possibly improve outcomes for melanoma patients on immunotherapy.

What could go wrong

This is a small, early feasibility study (24 participants) that is currently suspended. It is designed to test whether the study procedures work, not to prove any health benefits.

Conditions

The condition(s) this trial relates to.

melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.